Blue Cap AG is a private equity firm based in Munich, Germany, specializing in investments in middle market, late-stage, mature, turnaround, recapitalization, buyout, special situations, restructuring, corporate carve-outs, and growth capital. It focuses on SMEs, particularly B2B companies in industrial goods and services across sectors such as adhesives & coatings, plastics, business services, and medical. The firm targets investments in Germany, Austria, and Switzerland, typically ranging from $5.65 million to $28.3 million in equity, with target sales between 20 million ($23.46 million) and 200 million ($234.65 million), and EBITDA up to $10 million. Blue Cap prefers majority stakes and aims for exits within three to seven years, investing from its balance sheet capital. Founded in 2006, the firm operates with a long-term, value-driven approach.
0 transactions — 0 buys and 0 sales reported by Blue Cap AG executives.
0 institutional funds report a position on B7E in their latest SEC quarterly filing.
3 recent articles on B7E.
Beyond raw data, we aggregate and score every smart money signal to give you a unique view.
8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.
Detection of clustered purchases or sales by several executives in the same stock.
Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.
NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.
Spot marked changes in search interest around the stocks being followed.
Create your watchlist and receive a brief of events affecting your tickers.
This public page only shows a preview. The full analysis of B7E on the Kairos Insider dashboard includes:
Free signup · Pro €19/month or €190/year